Definitive Contract 75D30123C17410
Award Date
9/1/23
Potential Completion Date
8/31/25
Potential Value
$2M
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
AJ11 - General Science And Technology R&D Services; General Science And Technology; Basic Research
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Burlington, NC, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
100
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $47,916,380.00 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Laboratory Corporation of America (Labcorp) for serology testing services. The contract has a firm fixed price pricing type and a period of performance through March 5, 2022. The original solicitation was a pre-solicitation for laboratory testing of blood specimens to determine SARS-CoV-2 seroprevalence across the United States. The contract supports the CDC's public health initiatives...
This is a $91,693,500.00 firm-fixed-price definitive federal contract awarded by the Centers for Disease Control and Prevention (CDC) to Laboratory Corporation of America (Labcorp), a leading global life sciences company, for COVID-19 laboratory testing services. The contract has an ultimate completion date of April 22, 2025. Labcorp, a for-profit organization headquartered in Burlington, North Carolina, is the prime contractor and does not have any set-aside designation. The contract is not...
The Centers for Disease Control and Prevention (CDC) awarded a $1.249 million firm fixed price delivery order contract to Laboratory Corporation of America Holdings (LabCorp) for surge serology testing. Under the contract, LabCorp will provide serology testing services to the CDC in Burlington, North Carolina through December 2020 to support the agency's COVID-19 response efforts. No subcontractors or set aside designations were identified. The CDC is a component of the U.S. Department of Health...
Laboratory Corporation of America Holdings has been awarded a $533,990 firm fixed price delivery order by the Centers for Disease Control and Prevention in Pittsburgh for surge serology testing in support of coronavirus COVID-19 efforts. The contract runs from January 14, 2021 through April 26, 2021 and will see Laboratory Corporation perform serology testing services from its location in Burlington, North Carolina. No subcontractors or set aside designations were specified. This delivery...
This is a delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Laboratory Corporation of America (Labcorp), a leading global life sciences company. The contract, valued at $4,286,480.04, is part of the "Test Surge and Data Sharing" Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle. The contract, which is not set aside, will provide the CDC with a range of diagnostic testing services, including reference laboratory testing, genomic...
This federal contract was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Laboratory Corporation of America Holdings, a global life sciences company. The $169,142.60 firm-fixed-price purchase order is to support the supply of COVID-19 at-home test kits for fiscal year 2020. The contract does not have a set-aside designation. Laboratory Corporation of America Holdings has previously provided serology testing...
This is a firm fixed price purchase order awarded by the Department of the Army Medical Command to Laboratory Corporation Of America Holdings, a global life sciences leader that provides laboratory diagnostic services. The contract is for HLA testing services, with a potential value of $587,926.66 and a completion date of March 31, 2023. The contract is not set-aside. Laboratory Corporation Of America Holdings has previously provided serology testing services to support COVID-19 response efforts...
This is a $13,031,850.00 firm-fixed price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Laboratory Corporation of America (LabCorp) for genomic sequencing services. The contract has an ultimate completion date of May 14, 2022 and was awarded on December 26, 2021. LabCorp is a leading global life sciences company that provides diagnostic information services. They have extensive experience contracting with the federal government, including through their...
The U.S. Department of the Army Medical Command awarded a firm fixed price delivery order contract for $300,074.75 to Laboratory Corporation of America (LabCorp), a leading global life sciences company, for clinical reference laboratory testing services. This contract was not set aside and does not appear to be part of a larger contracting vehicle. LabCorp has been awarded numerous federal contracts to provide medical laboratory testing and analysis services in support of government healthcare...
This is a $5,273,743 firm fixed-price definitive contract awarded by the Office of Logistics and Acquisition Operations, a civilian agency, to Labcorp Early Development Laboratories Inc., a subsidiary of Laboratory Corporation of America Holdings. The contract does not have a set-aside designation. Under this contract, Labcorp will provide a range of laboratory testing and analytical services to support the federal government, including stability testing, potency and safety assays for drug...